{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:01Z","timestamp":1788995221158,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41401-026-01778-w","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:28:22Z","timestamp":1773134902000},"page":"2160-2170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FPR2\/ALX stimulation modulates microglia and natural killer cells to restrict autoimmune astrocytopathy"],"prefix":"10.1038","volume":"47","author":[{"given":"Cai-yun","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-li","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-yun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"1778_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","volume":"20","author":"A Uzawa","year":"2024","unstructured":"Uzawa A, Oertel FC, Mori M, Paul F, Kuwabara S. NMOSD and MOGAD: an evolving disease spectrum. Nat Rev Neurol. 2024;20:602\u201319.","journal-title":"Nat Rev Neurol"},{"key":"1778_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00401-024-02725-x","volume":"147","author":"A Nakajima","year":"2024","unstructured":"Nakajima A, Yanagimura F, Saji E, Shimizu H, Toyoshima Y, Yanagawa K, et al. Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ. Acta Neuropathol. 2024;147:76.","journal-title":"Acta Neuropathol"},{"key":"1778_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","volume":"21","author":"N Asavapanumas","year":"2021","unstructured":"Asavapanumas N, Tradtrantip L, Verkman AS. Targeting the complement system in neuromyelitis optica spectrum disorder. Expert Opin Biol Ther. 2021;21:1073\u201386.","journal-title":"Expert Opin Biol Ther"},{"key":"1778_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02249-1","volume":"18","author":"E Carnero Contentti","year":"2021","unstructured":"Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation. 2021;18:208.","journal-title":"J Neuroinflammation"},{"key":"1778_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology. 1999;53:1107\u201314.","journal-title":"Neurology"},{"key":"1778_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1474-4422(20)30392-6","volume":"20","author":"M Levy","year":"2021","unstructured":"Levy M, Fujihara K, Palace J. New therapies for neuromyelitis optica spectrum disorder. Lancet Neurol. 2021;20:60\u20137.","journal-title":"Lancet Neurol"},{"key":"1778_CR7","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.7150\/thno.107303","volume":"15","author":"C Qi","year":"2025","unstructured":"Qi C, Hao H, Zhang W, Fu Y, Han Y, Li J, et al. Targeting formyl peptide receptor 2 to suppress neuroinflammation in neuromyelitis optica spectrum disorder. Theranostics. 2025;15:4495\u2013506.","journal-title":"Theranostics"},{"key":"1778_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101602","volume":"59","author":"JA Lupisella","year":"2022","unstructured":"Lupisella JA, Shirude PS, Wurtz NR, Garcia RA. Formyl peptide receptor 2 and heart disease. Semin Immunol. 2022;59:101602.","journal-title":"Semin Immunol"},{"key":"1778_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1354074","volume":"15","author":"JH Lim","year":"2024","unstructured":"Lim JH, Neuwirth A, Chung KJ, Grossklaus S, Soehnlein O, Hajishengallis G, et al. Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation. Front Immunol. 2024;15:1354074.","journal-title":"Front Immunol"},{"key":"1778_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02174-3","volume":"18","author":"X Xu","year":"2021","unstructured":"Xu X, Gao W, Li L, Hao J, Yang B, Wang T, et al. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia\/macrophage polarization via FPR2\/ALX-dependent AMPK-mTOR pathway. J Neuroinflammation. 2021;18:119.","journal-title":"J Neuroinflammation"},{"key":"1778_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010;133:349\u201361.","journal-title":"Brain"},{"key":"1778_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106912","volume":"196","author":"H Ren","year":"2023","unstructured":"Ren H, Pan Y, Wang D, Hao H, Han R, Qi C, et al. CD22 blockade modulates microglia activity to suppress neuroinflammation following intracerebral hemorrhage. Pharmacol Res. 2023;196:106912.","journal-title":"Pharmacol Res"},{"key":"1778_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1074-7613(01)00134-0","volume":"14","author":"A Suzuki","year":"2001","unstructured":"Suzuki A, Yamaguchi MT, Ohteki T, Sasaki T, Kaisho T, Kimura Y, et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity. 2001;14:523\u201334.","journal-title":"Immunity"},{"key":"1778_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/BJ20112092","volume":"442","author":"L So","year":"2012","unstructured":"So L, Fruman DA. PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem J. 2012;442:465\u201381.","journal-title":"Biochem J"},{"key":"1778_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.smim.2015.08.001","volume":"27","author":"AJ Covarrubias","year":"2015","unstructured":"Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signaling. Semin Immunol. 2015;27:286\u201396.","journal-title":"Semin Immunol"},{"key":"1778_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri3901","volume":"15","author":"T Weichhart","year":"2015","unstructured":"Weichhart T, Hengstschlager M, Linke M. Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 2015;15:599\u2013614.","journal-title":"Nat Rev Immunol"},{"key":"1778_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169:381\u2013405.","journal-title":"Cell"},{"key":"1778_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/brain\/awad321","volume":"147","author":"C Qin","year":"2024","unstructured":"Qin C, Chen M, Dong MH, Yang S, Zhang H, You YF, et al. Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders. Brain. 2024;147:163\u201376.","journal-title":"Brain"},{"key":"1778_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3988\/jcn.2020.16.4.562","volume":"16","author":"J Jang","year":"2020","unstructured":"Jang J, Nam Y, Choi Y, Shin NY, An JY, Ahn KJ, et al. Paramagnetic rims in multiple sclerosis and neuromyelitis optica spectrum disorder: a quantitative susceptibility mapping study with 3-T MRI. J Clin Neurol. 2020;16:562\u201372.","journal-title":"J Clin Neurol"},{"key":"1778_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE. The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol. 2019;15:447\u201358.","journal-title":"Nat Rev Neurol"},{"key":"1778_CR21","doi-asserted-by":"crossref","unstructured":"Futokoro R, Hijioka M, Arata M, Kitamura Y. Lipoxin A4 receptor stimulation attenuates neuroinflammation in a mouse model of intracerebral hemorrhage. Brain Sci 2022;12:162.","DOI":"10.3390\/brainsci12020162"},{"key":"1778_CR22","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/glia.24227","volume":"70","author":"A Bhusal","year":"2022","unstructured":"Bhusal A, Nam Y, Seo D, Rahman MH, Hwang EM, Kim SC, et al. Cathelicidin-related antimicrobial peptide promotes neuroinflammation through astrocyte-microglia communication in experimental autoimmune encephalomyelitis. Glia. 2022;70:1902\u201326.","journal-title":"Glia"},{"key":"1778_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-6-45","volume":"6","author":"XD Pan","year":"2011","unstructured":"Pan XD, Zhu YG, Lin N, Zhang J, Ye QY, Huang HP, et al. Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer\u2019s disease. Mol Neurodegener. 2011;6:45.","journal-title":"Mol Neurodegener"},{"key":"1778_CR24","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401927R","volume":"38","author":"J Gao","year":"2024","unstructured":"Gao J, Su G, Liu J, Shen M, Zhang Z, Wang M. Formyl peptide receptors in the microglial activation: new perspectives and therapeutic potential for neuroinflammation. FASEB J. 2024;38:e70151.","journal-title":"FASEB J"},{"key":"1778_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-019-0766-7","volume":"7","author":"T Duan","year":"2019","unstructured":"Duan T, Smith AJ, Verkman AS. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. Acta Neuropathol Commun. 2019;7:112.","journal-title":"Acta Neuropathol Commun"},{"key":"1778_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104892","volume":"78","author":"J Remlinger","year":"2023","unstructured":"Remlinger J, Bagnoud M, Meli I, Massy M, Linington C, Chan A, et al. Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. Mult Scler Relat Disord. 2023;78:104892.","journal-title":"Mult Scler Relat Disord"},{"key":"1778_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02661-1","volume":"19","author":"S Nishiyama","year":"2022","unstructured":"Nishiyama S, Wright AE, Lotan I, Mikami T, Paul F, Aoki M, et al. Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder. J Neuroinflammation. 2022;19:296.","journal-title":"J Neuroinflammation"},{"key":"1778_CR28","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G, et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185:4135\u201352.e22.","journal-title":"Cell"},{"key":"1778_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-018-0265-1","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhang Y, Yi P, Dong W, Nalin AP, Zhang J, et al. The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells. Nat Immunol. 2019;20:10\u20137.","journal-title":"Nat Immunol"},{"key":"1778_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/jimmun\/vkaf012","volume":"214","author":"AJ Millan","year":"2025","unstructured":"Millan AJ, Allain V, Nayak I, Libang JB, Quijada-Madrid LM, Arakawa-Hoyt JS, et al. SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy. J Immunol. 2025;214:384\u201398.","journal-title":"J Immunol"},{"key":"1778_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ni930","volume":"4","author":"S Zompi","year":"2003","unstructured":"Zompi S, Hamerman JA, Ogasawara K, Schweighoffer E, Tybulewicz VL, Di Santo JP, et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol. 2003;4:565\u201372.","journal-title":"Nat Immunol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01778-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:20:19Z","timestamp":1788992419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01778-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01778-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}